<DOC>
	<DOCNO>NCT00609284</DOCNO>
	<brief_summary>The aim trial study efficacy add concomitant chemotherapy ( carboplatin/5FU ) Erbitux-radiotherapy patient locally advanced head neck cancer .</brief_summary>
	<brief_title>Randomized Trial Concomitant Chemotherapy Patients With Locally Advanced HNSCC Treated Radiotherapy-erbitux</brief_title>
	<detailed_description />
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Squamous cell carcinoma oral cavity , oropharynx , hypopharynx , larynx Stage III IV ( T0T4 , N0N2b , M0 ) Not resect Karnofsky PS &gt; =80 Informed consent sign Contra indication chemotherapy cetuximab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Stage III</keyword>
	<keyword>Stage IV</keyword>
	<keyword>locally advanced</keyword>
</DOC>